Reviva Pharmaceuticals Holdings Inc. Warrants (25/12/2025) RVPHW 深 滬
交易中 08-19 09:51:06 美东时间
0.0432
+0.003
+6.67%
華盛通- 最 高0.0432
- 今 開0.0432
- 成交量 2.00万股
- 最 低 0.0432
- 昨 收 0.0405
- 總市值 39.88万
- 52周最高 0.78
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.0226
- 委 比 -33.11%
- 總股本 923.17万
- 歷史最高 3.00
- 量 比 52.50
- 振 幅 0.00%
- 歷史最低 0.0226
- 每 手 1
- 風險率 0.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Reviva Pharmaceuticals Advances Schizophrenia Treatment
Reviva Pharmaceuticals Holdings, Inc. ( ($RVPH) ) has released its Q2 earnings....
今天 12:11
D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $3 Price Target
D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $3 price target.
08-18 19:27
Reviva Pharmaceuticals Holdings shares are trading higher after the company reportedbetter-than-expected Q2 EPS results.
Reviva Pharmaceuticals Holdings shares are trading higher after the company rep...
08-15 22:54
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Adial Pharmaceuticals (NASDAQ:ADIL) stock moved upwards by 19.6% to $0...
06-26 05:06
Reviva Pharmaceuticals announces public offering; shares down nearly 15%
Reviva Pharmaceuticals (NASDAQ:RVPH) plans to offer common stock or equivalents and warrants in a public offering. All securities in the offering will be sold by the company. Proceeds will support R&D...
06-26 04:28
Reviva Pharmaceuticals Holdings Announces Proposed Public Offering; No Size Or Amount Disclosed
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system
06-26 04:19
D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Maintains $3 Price Target
D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and maintains $3 price target.
06-03 19:23
Reviva Pharmaceuticals Completes Phase 3 Study for Schizophrenia
Reviva Pharmaceuticals Holdings ( ($RVPH) ) has issued an update. On June 2, 20...
06-02 19:29
D. Boral Capital Maintains Buy on Reviva Pharmaceuticals, Lowers Price Target to $3
D. Boral Capital analyst Jason Kolbert maintains Reviva Pharmaceuticals (NASDAQ:RVPH) with a Buy and lowers the price target from $8 to $3.
05-20 19:05
